Literature DB >> 17173889

Pax2 regulates neuronal-glial cell fate choice in the embryonic optic nerve.

Chadi Soukkarieh1, Eric Agius, Cathy Soula, Philippe Cochard.   

Abstract

During development, neural cell fate in the vertebrate optic nerve is restricted to the astroglial lineage. However, when isolated from the embryo and explanted in vitro, optic nerve progenitors generate neurons instead of astrocytes, suggesting that neuronal potentialities exist and are repressed in progenitors in vivo. Here we have investigated the mechanisms controlling cell fate in the optic nerve. The optic nerve is characterized by expression of the homeodomain transcription factor Pax2 which is maintained in differentiated astrocytes. We have observed that Pax2 is rapidly down-regulated in explanted optic nerves that generate neurons, and that its overexpression by electroporation in the optic nerve, or ectopically in the neural tube, is sufficient to block neuronal differentiation and allow glial development, showing that Pax2 plays a major role in controlling cell fate in the optic nerve. In vitro and ex vivo experiments further show that a signaling cascade that involves successively Sonic hedgehog and FGF is required to maintain Pax2 expression in optic nerve precursors whereby inhibiting the neuronal fate and promoting astroglial differentiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17173889     DOI: 10.1016/j.ydbio.2006.11.016

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  18 in total

1.  Comparative study of Pax2 expression in glial cells in the retina and optic nerve of birds and mammals.

Authors:  Jennifer Stanke; Holly E Moose; Heithem M El-Hodiri; Andy J Fischer
Journal:  J Comp Neurol       Date:  2010-06-15       Impact factor: 3.215

2.  The cellular bases of choroid fissure formation and closure.

Authors:  Cassidy S Bernstein; Mitchell T Anderson; Chintan Gohel; Kayleigh Slater; Jeffrey M Gross; Seema Agarwala
Journal:  Dev Biol       Date:  2018-05-24       Impact factor: 3.582

3.  Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma.

Authors:  Elaine C Johnson; Thomas A Doser; William O Cepurna; Jennifer A Dyck; Lijun Jia; Ying Guo; Wendi S Lambert; John C Morrison
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-25       Impact factor: 4.799

4.  Ectopic Pax2 expression in chick ventral optic cup phenocopies loss of Pax2 expression.

Authors:  Rachna Sehgal; Rachel Karcavich; Scott Carlson; Teri L Belecky-Adams
Journal:  Dev Biol       Date:  2008-04-11       Impact factor: 3.582

5.  Multiple roles for Pax2 in the embryonic mouse eye.

Authors:  Bernadett Bosze; Julissa Suarez-Navarro; Abdul Soofi; James D Lauderdale; Gregory R Dressler; Nadean L Brown
Journal:  Dev Biol       Date:  2021-01-09       Impact factor: 3.582

6.  Characterization of the antigenic phenotype of αB-crystallin-expressing peripapillary glial cells in the developing chick retina.

Authors:  Ji Young Kim; Hyun Joon Sohn; Je Hoon Seo
Journal:  Anat Cell Biol       Date:  2011-03-31

7.  Characterization of Pax2 expression in the goldfish optic nerve head during retina regeneration.

Authors:  Marta Parrilla; Concepción Lillo; M Javier Herrero-Turrión; Rosario Arévalo; José Aijón; Juan M Lara; Almudena Velasco
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

Review 8.  Seeing stars: Development and function of retinal astrocytes.

Authors:  Caitlin E Paisley; Jeremy N Kay
Journal:  Dev Biol       Date:  2021-07-11       Impact factor: 3.148

9.  PAX2 Expression in Ovarian Cancer.

Authors:  Huijuan Song; Suet-Yan Kwan; Daisy I Izaguirre; Zhifei Zu; Yvonne T Tsang; Celestine S Tung; Erin R King; Samuel C Mok; David M Gershenson; Kwong-Kwok Wong
Journal:  Int J Mol Sci       Date:  2013-03-15       Impact factor: 5.923

10.  The cell-matrix interface: a possible target for treating retinal vascular related pathologies.

Authors:  Gopalan Gnanaguru; William J Brunken
Journal:  J Ophthalmic Vis Res       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.